Cosmo Pharmaceuticals N.V. (0RGI.L) LSE

90.80

+1.79866(+2.02%)

Updated at December 05 12:01PM

Currency In CHF

Valuation

Market Cap1.11B
Enterprise Value1.07B
P/E Ratio27.41
PEG Ratio-0.46
Price/Sales Ratio8.31
Price/Book Ratio3.29
Enterprise/Revenue8.05
Enterprise/EBITDA19.23

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.3
Operating Margin0.33

Management Effectiveness

Return On Assets0.09
Return On Equity0.12

Income Statement

Revenue266.79M
Revenue/Share11.45
Gross Profit246.92M
EBITDA165.71M
Net Income133.24M
Diluted EPS8.12

Balance Sheet

Total Cash126.63M
Total Cash/Share3.26
Total Debt2.7M
Total Debt/Equity0.01
Current Ratio3.84
Book Value Per Share29.33

Price History

52-Week Change44.37
52-Week High89
52-Week Low33.75
Moving Average 50 Days63.2
Moving Average 200 Days48.12

Statistics

Average Volume1,442
Shares Outstanding15.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2.05
Trailing Annual Dividend Yield2.15
Payout Ratio1.02
Last Split FactorN/A
Last Split DateN/A